


Healthcare Industry News: LineUP
News Release - July 18, 2008
AcuNetx Announces Change in Management Lineup
TORRANCE, Calif.--(HSMN NewsFeed)--AcuNetx Inc. (OTCBB:ANTX ) today announced that it had accepted the resignation of Ronald A. Waldorf, President and CEO of the company. In a letter to the company’s Board, Mr. Waldorf stated that “It is with a heavy heart that I tender my resignation, but my family needs me and I cannot, in all good conscience, ignore those nearest me. Nevertheless, I can be counted on to provide on-going guidance and counsel as a Board Member.”Mr. Waldorf’s position will be filled on an interim basis by Mr. Robert S. Corrigan, Chairman of AcuNetx’s Board and a seasoned executive with more than twenty-five years of experience in corporate finance and business development.
On behalf of the Board of Directors, Mr. Corrigan thanked Mr. Waldorf for his efforts and wished the very best to him and his family.
Commenting on his new assignment, Mr. Corrigan stated, "I am enthusiastic and optimistic facing the challenge of building this company and am intent on growing sales, shoring up the balance sheet and strengthening our ties with the financial community.”
About AcuNetx, Inc.:
AcuNetx markets a diverse line of diagnostic, analytical and therapeutic tools for the medical community (audiologists, neurologists, otolaryngologists and physical therapists as well as hospitals, clinics, and extended care facilities) and law enforcement agencies and is one of the U.S.’s leading suppliers of VNG systems and Balance Assessment/Rehabilitation equipment. AcuNetx is headquartered in Torrance, CA. For more information please visit www.acunetx.com.
Safe Harbor for Forward-Looking Statements:
This news release contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Readers are cautioned that such forward-looking statements represent management’s opinion. While management believes such representations to be accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company’s operations and business prospects are always subject to risks and uncertainties. Important factors that may cause actual results to differ are set forth in the company’s periodic filings with the U.S. Securities and Exchange Commission.
Source: AcuNetx
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
